- $156.23bn
- $160.39bn
- $23.09bn
- 96
- 18
- 98
- 81
Annual income statement for Amphenol, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 10,876 | 12,623 | 12,555 | 15,223 | 23,095 |
| Cost of Revenue | |||||
| Gross Profit | 3,402 | 4,028 | 4,084 | 5,158 | 8,518 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 8,771 | 10,037 | 9,990 | 12,066 | 17,226 |
| Operating Profit | 2,105 | 2,586 | 2,565 | 3,157 | 5,869 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,989 | 2,467 | 2,455 | 3,012 | 5,601 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,580 | 1,917 | 1,946 | 2,442 | 4,305 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1,591 | 1,902 | 1,928 | 2,424 | 4,270 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,591 | 1,902 | 1,928 | 2,424 | 4,270 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.3 | 1.55 | 1.57 | 2.01 | 3.4 |
| Dividends per Share |